J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in, International Journal of Cancer, vol.127, issue.12, pp.2893-2917, 2008.

L. M. Brown, S. S. Devesa, and W. Chow, Incidence of adenocarcinoma of the esophagus among white Americans by sex, Gastroenterology Research and Practice, vol.9

, Journal of the National Cancer Institute, vol.100, issue.16, pp.1184-1187, 2008.

H. Pohl and H. G. Welch, The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence, Journal of the National Cancer Institute, vol.97, issue.2, pp.142-146, 2005.

D. P. Kelsen, R. Ginsberg, and T. F. Pajak, Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer, The New England Journal of Medicine, vol.339, issue.27, pp.1979-1984, 1998.

M. Stahl, M. K. Walz, and M. Stuschke, Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction, Journal of Clinical Oncology, vol.27, issue.6, pp.851-856, 2009.

P. Van-hagen, M. C. Hulshof, and J. J. Van-lanschot, Preoperative chemoradiotherapy for esophageal or junctional cancer, The New England Journal of Medicine, vol.366, issue.22, pp.2074-2084, 2012.

R. Gertler, H. J. Stein, and R. Langer, Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the new union internationale contre le cancer/American joint cancer committee staging system, Annals of Surgery, vol.253, issue.4, pp.689-698, 2011.

V. Gebski, B. Burmeister, B. M. Smithers, K. Foo, J. Zalcberg et al., Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a metaanalysis, Lancet Oncology, vol.8, issue.3, pp.226-234, 2007.

K. M. Sjoquist, B. H. Burmeister, and B. M. Smithers, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, The Lancet Oncology, vol.12, issue.7, pp.681-692, 2011.

J. R. Siewert, A. H. Holscher, K. Becker, and W. Gossner, Cardia cancer: attempt at a therapeutically relevant classification, Chirurg, vol.58, issue.1, pp.25-32, 1987.

J. R. Siewert and H. J. Stein, Classification of adenocarcinoma of the oesophagogastric junction, British Journal of Surgery, vol.85, issue.11, pp.1457-1459, 1998.

S. Hasegawa, T. Yoshikawa, and T. Aoyama, Esophagus or stomach? The seventh TNM classification for siewert type II/III junctional adenocarcinoma, Annals of Surgical Oncology, vol.20, issue.3, pp.773-779, 2013.

D. Cunningham, W. H. Allum, and S. P. Stenning, Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, The New England Journal of Medicine, vol.355, issue.1, pp.11-20, 2006.

M. Ychou, V. Boige, and J. Pignon, Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial, Journal of Clinical Oncology, vol.29, issue.13, pp.1715-1721, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00596037

S. E. Edge, D. R. Byrd, and C. C. Compton, , 2009.

M. Schemper and T. L. Smith, A note on quantifying follow-up in studies of failure time, Controlled Clinical Trials, vol.17, issue.4, pp.343-346, 1996.

E. L. Kaplan and P. Meier, Nonparametric estimation from incomplete observations, Journal of the American Statistical Association, vol.53, pp.457-481, 1958.

D. R. Cox, Regression models and life-tables, Journal of the Royal Statistical Society, Series B: Methodological, vol.34, pp.187-220, 1972.

B. H. Burmeister, J. M. Thomas, and E. A. Burmeister, Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial, European Journal of Cancer, vol.47, issue.3, pp.354-360, 2011.

P. Van-hagen, B. P. Wijnhoven, and P. Nafteux, Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer, British Journal of Surgery, vol.100, issue.2, pp.267-273, 2013.

K. Wang, C. Yang, and L. Duan, Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China, Tumori, vol.98, issue.5, pp.568-574, 2012.

U. Ronellenfitsch, M. Schwarzbach, and R. Hofheinz, Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus, Cochrane Database of Systematic Reviews, issue.5, 2013.

Y. Hosokawa, T. Kinoshita, and M. Konishi, Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan, Annals of Surgical Oncology, vol.19, issue.2, pp.677-683, 2012.

W. Xiao, K. Ma, L. Peng, Q. Li, L. Chen et al., Characteristics of lymphatic metastasis and surgical approach of adenocarcinoma of the esophagogastric junction, Zhonghua Wei Chang Wai Ke Za Zhi, vol.15, issue.9, pp.897-900, 2012.

M. Reeh, S. Mina, and M. Bockhorn, Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction, British Journal of Surgery, vol.99, issue.10, pp.1406-1414, 2012.

N. J. Curtis, F. Noble, I. S. Bailey, J. J. Kelly, J. P. Byrne et al., The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastrooesophageal junction, Journal of Surgical Oncology, vol.109, issue.3, pp.202-207, 2014.

L. Kleinberg, Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome, Seminars in Radiation Oncology, vol.23, issue.1, pp.38-50, 2013.